ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

228
Analysis
Health Care • Japan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
•05 Sep 2016 13:45

Short Sell Research Vs The Japan Stock Market Blob

Two recent press articles "Muddy Waters and Andrew Left: the short sellers having a ball" (...

•29 Aug 2016 22:03

Japan Pharma Hits 52 Week Low

The Topix pharmaceutical index (TPPHRM) fell to 2,355 just after the lunch break in Tokyo on Friday 19th August, before recovering to 2,377, with...

•20 Aug 2016 01:02

JAPAN FLOW III:  The Mechanics of BOJ Buying

This is the latest in a series of JAPAN FLOW regarding recent and forward flow dynamics of Japan equities.The first two are:    JAPAN FLOW I:  The...

Logo
523 Views
Share
•09 Aug 2016 18:52

A 'heads Up' on Changing World Heights

A comprehensive world survey of population heights over the last century has thrown up some surprising results. Americans have had the smallest...

Logo
350 Views
Share
•06 Aug 2016 18:07

Death Rattle for Defensives?

While it is not a given that a switch from a high growth, high interest rate environment to a low growth, low interest rate environment is a good...

x